Kolexia
Nougairede Antoine
Pharmacien
Hôpital La Timone Enfants
Marseille, France
112 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Grippe humaine Encéphalite Fièvre chikungunya Infections à alphavirus Infections à entérovirus Entorses et foulures Infections à coronavirus Encéphalites à tiques

Industries

M3 Global Research Ltd
14 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.
Antiviral research   24 janvier 2024
Different viral genes modulate virulence in model mammal hosts and vector competence in Mediterranean basin lineage 1 West Nile virus strains.
Frontiers in microbiology   17 janvier 2024
Outbreak of adenovirus D8 in a neonatal intensive care unit involving multiple simultaneous transmission pathways.
The Journal of hospital infection   26 juillet 2023
Simultaneous quantitation of favipiravir and its hydroxide metabolite in human plasma and hamster matrices using a UPLC-MS/MS method.
Biomedical chromatography : BMC   22 juin 2023
Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model.
Heliyon   30 mai 2023
Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model.
Antiviral research   18 mai 2023
Acute hepatitis associated with an echovirus 9 infection in a heart transplant recipient.
Journal of medical virology   09 novembre 2022
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Nature communications   30 août 2022
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
Microorganisms   12 août 2022
In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5.
Scientific reports   23 juillet 2022